Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.

In Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton 'Quantitative Magnetic Resonance Spectroscopy' (qMRS) to characterize th...

Full description

Bibliographic Details
Main Authors: Anders Tisell, Olof Dahlqvist Leinhard, Jan Bertus Marcel Warntjes, Anne Aalto, Örjan Smedby, Anne-Marie Landtblom, Peter Lundberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3629257?pdf=render
id doaj-127707baa5244c649f79ec815983e29b
record_format Article
spelling doaj-127707baa5244c649f79ec815983e29b2020-11-24T21:17:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e6181710.1371/journal.pone.0061817Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.Anders TisellOlof Dahlqvist LeinhardJan Bertus Marcel WarntjesAnne AaltoÖrjan SmedbyAnne-Marie LandtblomPeter LundbergIn Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton 'Quantitative Magnetic Resonance Spectroscopy' (qMRS) to characterize the NAWM and thalamus both in atypical 'Clinically Definite MS' (CDMS) patients, MRI(neg) (N = 15) with very few lesions (two or fewer lesions), and in typical CDMS patients, MRI(pos) (N = 20) with lesions, in comparison with healthy control subjects (N = 20). In addition, the metabolite concentrations were also correlated with extent of brain atrophy measured using Brain Parenchymal Fraction (BPF) and severity of the disease measured using 'Multiple Sclerosis Severity Score' (MSSS). Elevated concentrations of glutamate and glutamine (Glx) were observed in both MS groups (MRI(neg) 8.12 mM, p<0.001 and MRI(pos) 7.96 mM p<0.001) compared to controls, 6.76 mM. Linear regressions of Glx and total creatine (tCr) with MSSS were 0.16 ± 0.06 mM/MSSS (p = 0.02) for Glx and 0.06 ± 0.03 mM/MSSS (p = 0.04) for tCr, respectively. Moreover, linear regressions of tCr and myo-Inositol (mIns) with BPF were -6.22 ± 1.63 mM/BPF (p<0.001) for tCr and -7.71 ± 2.43 mM/BPF (p = 0.003) for mIns. Furthermore, the MRI(pos) patients had lower N-acetylaspartate and N-acetylaspartate-glutamate (tNA) and elevated mIns concentrations in NAWM compared to both controls (tNA: p = 0.04 mIns p<0.001) and MRI(neg) (tNA: p = 0.03 , mIns: p = 0.002). The results suggest that Glx may be an important marker for pathology in non-lesional white matter in MS. Moreover, Glx is related to the severity of MS independent of number of lesions in the patient. In contrast, increased glial density indicated by increased mIns and decreased neuronal density indicated by the decreased tNA, were only observed in NAWM of typical CDMS patients with white matter lesions.http://europepmc.org/articles/PMC3629257?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Anders Tisell
Olof Dahlqvist Leinhard
Jan Bertus Marcel Warntjes
Anne Aalto
Örjan Smedby
Anne-Marie Landtblom
Peter Lundberg
spellingShingle Anders Tisell
Olof Dahlqvist Leinhard
Jan Bertus Marcel Warntjes
Anne Aalto
Örjan Smedby
Anne-Marie Landtblom
Peter Lundberg
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
PLoS ONE
author_facet Anders Tisell
Olof Dahlqvist Leinhard
Jan Bertus Marcel Warntjes
Anne Aalto
Örjan Smedby
Anne-Marie Landtblom
Peter Lundberg
author_sort Anders Tisell
title Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
title_short Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
title_full Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
title_fullStr Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
title_full_unstemmed Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
title_sort increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal mr imaging brain scans.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description In Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton 'Quantitative Magnetic Resonance Spectroscopy' (qMRS) to characterize the NAWM and thalamus both in atypical 'Clinically Definite MS' (CDMS) patients, MRI(neg) (N = 15) with very few lesions (two or fewer lesions), and in typical CDMS patients, MRI(pos) (N = 20) with lesions, in comparison with healthy control subjects (N = 20). In addition, the metabolite concentrations were also correlated with extent of brain atrophy measured using Brain Parenchymal Fraction (BPF) and severity of the disease measured using 'Multiple Sclerosis Severity Score' (MSSS). Elevated concentrations of glutamate and glutamine (Glx) were observed in both MS groups (MRI(neg) 8.12 mM, p<0.001 and MRI(pos) 7.96 mM p<0.001) compared to controls, 6.76 mM. Linear regressions of Glx and total creatine (tCr) with MSSS were 0.16 ± 0.06 mM/MSSS (p = 0.02) for Glx and 0.06 ± 0.03 mM/MSSS (p = 0.04) for tCr, respectively. Moreover, linear regressions of tCr and myo-Inositol (mIns) with BPF were -6.22 ± 1.63 mM/BPF (p<0.001) for tCr and -7.71 ± 2.43 mM/BPF (p = 0.003) for mIns. Furthermore, the MRI(pos) patients had lower N-acetylaspartate and N-acetylaspartate-glutamate (tNA) and elevated mIns concentrations in NAWM compared to both controls (tNA: p = 0.04 mIns p<0.001) and MRI(neg) (tNA: p = 0.03 , mIns: p = 0.002). The results suggest that Glx may be an important marker for pathology in non-lesional white matter in MS. Moreover, Glx is related to the severity of MS independent of number of lesions in the patient. In contrast, increased glial density indicated by increased mIns and decreased neuronal density indicated by the decreased tNA, were only observed in NAWM of typical CDMS patients with white matter lesions.
url http://europepmc.org/articles/PMC3629257?pdf=render
work_keys_str_mv AT anderstisell increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans
AT olofdahlqvistleinhard increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans
AT janbertusmarcelwarntjes increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans
AT anneaalto increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans
AT orjansmedby increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans
AT annemarielandtblom increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans
AT peterlundberg increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans
_version_ 1726011533734969344